Brief: Sakar Healthcare Entered Into Agreement With Ferring Pharmaceuticals And Bazell Pharma Llp
18/05/2023 05:59
May 18 (Reuters) - Sakar Healthcare Ltd SAKA.NS :
* ENTERED INTO AGREEMENT THIS CONSECUTIVE WEEK WITH FERRING
PHARMACEUTICALS AND BAZELL PHARMA LLP
* AGREEMENT FOR DEVELOPING NOVEL DRUG DELIVERY SYSTEM (NDDS)
FOR
TWO OF ONCOLOGY PRODUCTS
Source text for Eikon: ID:nNSE2WW3N5
Further company coverage: SAKA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sakar Healthcare
See all newsIndia's Sakar Healthcare jumps on regulatory approvals for cancer drugs
Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
Brief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar